HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.